Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;15(3):245-254.
doi: 10.1007/s11904-018-0393-0.

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C

Affiliations
Review

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C

Asher J Schranz et al. Curr HIV/AIDS Rep. 2018 Jun.

Abstract

Purpose of review: This article reviews recent epidemiologic trends in HIV and hepatitis C virus (HCV) and strategies for treatment and prevention of these infections as they relate to the opioid epidemic.

Recent findings: Among people who inject drugs (PWID) in the United States (US), HIV diagnoses are decreasing, while HCV is increasing. Care for HIV and HCV relies heavily on specialist infrastructure, which is lacking in rural areas. Antiretrovirals for HIV and direct-acting antivirals for HCV are effective among PWID, yet multiple barriers make it difficult for rural injectors to access these treatments. Similarly, access to syringe service programs, medication-assisted therapy for opioid addiction, and pre-exposure prophylaxis for HIV are all limited in rural areas. Previous research on HIV and HCV among PWID has focused on urban or international populations, yet the US opioid epidemic is moving away from metropolitan centers. Increasing rurality of opioid injection brings unique challenges in treatment and prevention. Research into the care of HIV, HCV, and opioid use disorder among rural populations is urgently needed.

Keywords: HIV; Hepatitis C; Opiate-related disorders; Rural health; Substance abuse, intravenous.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Diagnoses of human immunodeficiency virus (HIV) infection among persons who inject drugs — National HIV Surveillance System, United States, 2008–2014
Reprinted from Wejnert et. al., Morbidity and Mortality Weekly Report, 2016 [7].
Figure 2
Figure 2. Active physicians per 100,000 population by physician specialty and urbanization level: United States, 2010
Reproduced with permission using data from Meit et. al., The 2014 Update of the Rural-Urban Chartbook [34,35].

References

    1. Peters PJ, Pontones P, Hoover KW, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375:229–39. - PubMed
    1. DeBeck K, Wood E, Dong H, et al. Non-medical prescription opioid use predicts injection initiation among street-involved youth. Int J Drug Policy. 2016;34:96–100. - PMC - PubMed
    1. Al-Tayyib AA, Koester S, Riggs P. Prescription opioids prior to injection drug use: Comparisons and public health implications. Addict Behav. 2017;65:224–8. - PMC - PubMed
    1. Jones CM, Logan J, Gladden RM, et al. Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2015;64:719–25. - PMC - PubMed
    1. Kolodny A, Courtwright DT, Hwang CS, et al. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annu Rev Public Health. 2015;36:559–74. - PubMed

Publication types

MeSH terms

Substances